2024 annual financial data
Alzamend Neuro 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -9,937,645 USD and net income was -9,947,746 USD.
Operating cash flow was -8,269,993 USD.
Get free Alzamend Neuro email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,937,645 USD
- Net income
- -9,947,746 USD
- Operating cash flow
- -8,269,993 USD